An extension of its core SAIL™ portfolio, company’s new Sentinel provides lab-driven insights for earliest possible signaling and expedited decision-making.
Gradient AI, a prominent enterprise software provider of artificial intelligence solutions for the insurance industry, has launched Sentinel, a new tool that surfaces potentially high-cost conditions before they enter the claims process. The new solution's core benefit is its ability to mine relevant insight from lab results, which are typically the first data point in a member's care journey. For underwriters, this provides earliest possible indications of potentially high-cost conditions – well before they appear on medical or pharmacy claims.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261118590885/en/

Sentinel's core benefit is its ability to mine relevant insight from lab results, which are typically the first data point in a member's care journey. For underwriters, this new solution, an extension of Gradient AI's SAIL™ portfolio, provides earliest possible indications of potentially high-cost conditions – well before they appear on medical or pharmacy claims.
Gradient AI’s newest solution leans into a longstanding group health dynamic: underwriters who see risk first gain substantial, often decisive competitive advantages. Sentinel offers opportunities to virtually eliminate the lag period between when a condition is first apparent via lab work and when it appears in a medical or pharmacy claim. For underwriters, closing that insight and time gap significantly diminishes the likelihood of presenting pricing based on incomplete information.
Sentinel is being offered as an add-on to SAIL™, Gradient AI’s core group health underwriting and stop-loss ecosystem. Trained on millions of medical records and health data points, SAIL™ fosters data-driven decision-making by analyzing medical and prescription patterns to quantify group health risk. The solution has proven adept at uncovering hidden comorbidities, severity trends, and high-cost claimants – toward the goals of enabling more accurate pricing strategies, faster quote turnaround times, straight-through processing, and reserve optimization.
As an extension to Gradient AI’s SAIL™, Sentinel’s benefits come without the complexity of onboarding a new system. Using the same census SAIL™ relies upon, Sentinel layers early signal, lab-based intelligence onto the medical- and pharmacy-stage claim insights underwriters have already come to trust. The result is a fuller risk picture with negligible ramp-up time and no learning curve.
"Sentinel speaks to one simple truth in health underwriting: the sooner the better," said Marc Jeffreys Health GM, Health Gradient AI. "By swimming further upstream into lab stages, Sentinel presents critical member information at the earliest possible timeframe. From there, that insight combines with the medical, pharmacy, and other claims data offered through our existing SAIL™ ecosystem to provide a more robust risk picture. The immediate, tangible results include more accurate rate-setting and improved Medical Loss Ratio performance."
About Gradient AI
Gradient AI is a leading decision-intelligence partner for the insurance industry, providing customers with competitive advantages by revealing risk others might miss – then translating those insights into stronger performance and real-world impact.
Gradient AI's platform harnesses a vast industry data lake — tens of millions of policies and claims enriched with economic, health, geographic, and demographic signals — integrating cleanly with existing workflows to make complex risk clear, usable, and actionable.
Customers include recognized carriers, brokers, consultants, MGAs, MGUs, TPAs, risk pools, and PEOs. To learn more, visit gradientai.com or follow the company on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261118590885/en/
Using the same census SAIL™ relies upon, Sentinel layers early signal, lab-based intelligence onto the medical- and pharmacy-stage claim insights underwriters have already come to trust. The result is a fuller risk picture with no learning curve.
Contacts
Christopher Dale
Turchette Agency
(973) 227-8080, ext. 3
cdale@turchette.com
If you believe this article contains misleading, harmful, or spam content, please let us know.
Report this article